These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1910927)

  • 21. [Dystrophin gene expression in patients with Duchenne muscular dystrophy after myoblast transplantation].
    Shishkin SS; Terekhov SM; Krokhina TB; Shakhovskaia NI; Podobedova AN; Linnaia GF; Tarasov VI; Ovchinnikov VI; Krakhmaleva IN; Zakharov SF; Ershova ES; Limborskaia SA; Pogoda TV; Zotikov EA; Kut'ina RM; Tarksh MA; Sukhorukov VS; Gerasimova NL
    Genetika; 2001 Aug; 37(8):1104-11. PubMed ID: 11642111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progress towards gene therapy for Duchenne muscular dystrophy.
    Hauser MA; Chamberlain JS
    J Endocrinol; 1996 Jun; 149(3):373-8. PubMed ID: 8691095
    [No Abstract]   [Full Text] [Related]  

  • 23. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
    Karpati G; Acsadi G
    Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Advances in genome editing technologies for treating muscular dystrophy.].
    Makita Y; Hozumi H; Hotta A
    Clin Calcium; 2017; 27(3):391-399. PubMed ID: 28232654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient page. Gene therapy and muscular dystrophies.
    Karceski S
    Neurology; 2008 Jul; 71(4):e6-8. PubMed ID: 18645160
    [No Abstract]   [Full Text] [Related]  

  • 26. Duchenne muscular dystrophy.
    Matsuo M
    Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():166-71. PubMed ID: 8629099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duchenne muscular dystrophy: the gene and the protein.
    Love DR; Davies KE
    Mol Biol Med; 1989 Feb; 6(1):7-17. PubMed ID: 2666821
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gene therapy in muscular dystrophy].
    Takeda S; Nabeshima Y
    Tanpakushitsu Kakusan Koso; 1995 Dec; 40(17):2765-71. PubMed ID: 8584734
    [No Abstract]   [Full Text] [Related]  

  • 29. Relatively low proportion of dystrophin gene deletions in Israeli Duchenne and Becker muscular dystrophy patients.
    Shomrat R; Gluck E; Legum C; Shiloh Y
    Am J Med Genet; 1994 Feb; 49(4):369-73. PubMed ID: 8160727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of Duchenne muscular dystrophy: past, present, and future.
    Davies KE; Tinsley JM; Blake DJ
    Ann N Y Acad Sci; 1995 Jun; 758():287-96. PubMed ID: 7625698
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular therapy for muscular dystrophy].
    Shimizu Y; Takeda S
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():650-3. PubMed ID: 20976941
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges for gene therapy for muscular dystrophy.
    Mendell JR; Clark KR
    Curr Neurol Neurosci Rep; 2006 Jan; 6(1):47-56. PubMed ID: 16469271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On dystrophin abundance and C-terminal missense mutations in dystrophinopathies.
    Oexle K; Heyer R
    Ann Neurol; 1999 Jul; 46(1):137-8. PubMed ID: 10401797
    [No Abstract]   [Full Text] [Related]  

  • 34. Advances in Muscular Dystrophies.
    Kang PB; Griggs RC
    JAMA Neurol; 2015 Jul; 72(7):741-2. PubMed ID: 25985443
    [No Abstract]   [Full Text] [Related]  

  • 35. Muscular dystrophy--reason for optimism?
    Burton EA; Davies KE
    Cell; 2002 Jan; 108(1):5-8. PubMed ID: 11792315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dilemma of manifesting carriers in the context of myoblast transplantation.
    Kunkel LM
    Adv Exp Med Biol; 1990; 280():285-6. PubMed ID: 2248149
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapeutic trials with galantamine in Duchenne-Griesinger-type progressive muscular dystrophy].
    SERAFINI L; BONVINI E
    Rass Clin Sci; 1961 Jan; 37():20-4. PubMed ID: 13750156
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reflexions apropos of recent progresses in molecular genetics of myopathies].
    Kaplan JC
    Arch Pediatr; 1995 Aug; 2(8):715-8. PubMed ID: 7550833
    [No Abstract]   [Full Text] [Related]  

  • 39. Genetics and biochemistry of muscular dystrophy.
    N Engl J Med; 1965 Nov; 273(20):1107-8. PubMed ID: 5834823
    [No Abstract]   [Full Text] [Related]  

  • 40. Dystrophin.
    Ferrer X; Larriviere M; Coquet M; Julien J
    Neurology; 1992 Aug; 42(8):1645. PubMed ID: 1463519
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.